Top

Langenbeck's Archives of Surgery

Published in:

01-01-2009 | Original Article

Gastric remnant cancer: an old problem with novel concerns

Authors: Ozgur Firat, Adem Guler, Murat Sozbilen, Sinan Ersin, Hasan Kaplan

Published in: Langenbeck's Archives of Surgery | Issue 1/2009

Abstract

Background and aims

The patients with cancers in the remnant stomachs after previous partial resections for benign diseases constitute a peculiar subset of the patients with gastric cancer. They are generally at advanced stages on admissions due to disregarding the symptoms related to cancer.

Patients and methods

Twenty six patients with cancer arising from the remnant stomach were analyzed. Clinicopathologic features such as age, gender, time interval between the initial operation and diagnosis of gastric remnant cancer, preoperative symptoms, surgical management, and tumor characteristics like size, location, histopathology, depth of invasion, lymph node involvement, presence of distant metastasis, and stages were documented.

Results

None of the cancers were diagnosed by routine surveillance and all the patients were symptomatic at the time of diagnosis. Twenty five patients were qualified for surgery. The resectability rate was 61% (n = 16). The ability to perform a curative resection and tumor location at the anastomotic site were determined as the factors significantly influencing survival (p < 0.05).

Conclusion

Curative resection has to be the goal of surgical management in patients with gastric remnant cancer. Concerning clinician should be sceptical about a newly developing cancer in order to detect it in an early stage and enhance resectability.

Ohashi M, Katai H, Fukagawa T, Gotoda T, Sano T, Sasako M (2007) Cancer of the gastric stump following distal gastrectomy for cancer. Br J Surg 94(1):92–95 doi:10.1002/bjs.5538 PubMedCrossRef

Thorban S, Böttcher K, Etter M, Roder JD, Busch R, Siewert JR (2000) Prognostic factors in gastric stump carcinoma. Ann Surg 231(2):188–194 doi:10.1097/00000658-200002000-00006 PubMedCrossRef

Safatle-Ribeiro AV, Ribeiro U Jr, Reynolds JC (1998) Gastric stump cancer: what is the risk? Dig Dis 16(3):159–168 doi:10.1159/000016860 PubMedCrossRef

Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K et al (1996) Gastric stump carcinoma after partial gastrectomy for benign gastric lesion: what is feasible as standard surgical treatment? J Surg Oncol 63(2):119–124 doi:10.1002/(SICI)1096-9098(199610)63:2<119::AID-JSO9>3.0.CO;2-H PubMedCrossRef

Orlando R 3rd, Welch JP (1981) Carcinoma of the stomach after gastric operation. Am J Surg 141(4):487–491 doi:10.1016/0002-9610(81)90145-8 PubMedCrossRef

Han SL, Hua YW, Wang CH, Ji SQ, Zhuang J (2003) Metastatic pattern of lymph node and surgery for gastric stump cancer. J Surg Oncol 82(4):241–246 doi:10.1002/jso.10228 PubMedCrossRef

Imada T, Rino Y, Takahashi M, Shiozawa M, Hatori S, Noguchi Y et al (1998) Clinicopathologic differences between gastric remnant cancer and primary cancer in the upper third of the stomach. Anticancer Res 18(1A):231–235PubMed

An JY, Choi MG, Noh JH, Sohn TS, Kim S (2007) The outcome of patients with remnant primary gastric cancer compared with those having upper one-third gastric cancer. Am J Surg 194(2):143–147 doi:10.1016/j.amjsurg.2006.10.034 PubMedCrossRef

Schaefer N, Sinning C, Standop J, Overhaus M, Hirner A, Wolff M (2007) Treatment and prognosis of gastric stump carcinoma in comparison with primary proximal gastric cancer. Am J Surg 194(1):63–67 doi:10.1016/j.amjsurg.2006.12.037 PubMedCrossRef

10.

Newman E, Brennan MF, Hochwald SN, Harrison LE, Karpeh MS Jr (1997) Gastric remnant carcinoma: just another proximal gastric cancer or a unique entity? Am J Surg 173(4):292–297 doi:10.1016/S0002-9610(96)00403-5 PubMedCrossRef

11.

Balfour DC (1922) Factors influencing the life expectancy of patients operated on for gastric ulcer. Ann Surg 76(3):405–408 doi:10.1097/00000658-192209000-00014 PubMedCrossRef

12.

Sobin LH, Wittekind C (eds) (2002) TNM Classification of malignant tumors (6th ed). Wiley-Liss, New York

13.

Sinning C, Schaefer N, Standop J, Hirner A, Wolff M (2007) Gastric stump carcinoma-epidemiology and current concepts in pathogenesis and treatment. Eur J Surg Oncol 33(2):133–139 doi:10.1016/j.ejso.2006.09.006 PubMedCrossRef

14.

Kondo K (2002) Duodenogastric reflux and gastric stump carcinoma. Gastric Cancer 5(1):16–22 doi:10.1007/s101200200002 PubMedCrossRef

15.

Tanigawa N, Nomura E, Niki M, Shinohara H, Nishiguchi K, Okuzawa M et al (2002) Clinical study to identify specific characteristics of cancer newly developed in the remnant stomach. Gastric Cancer 5(1):23–28 doi:10.1007/s101200200003 PubMedCrossRef

16.

Takeno S, Noguchi T, Kimura Y, Fujiwara S, Kubo N, Kawahara K (2006) Early and late gastric cancer arising in the remnant stomach after distal gastrectomy. Eur J Surg Oncol 32(10):1191–1194 doi:10.1016/j.ejso.2006.04.018 PubMedCrossRef

17.

Kondo K, Kojima H, Akiyama S, Ito K, Takagi H (1995) Pathogenesis of adenocarcinoma induced by gastrojejunostomy in Wistar rats: role of duodenogastric reflux. Carcinogenesis 16(8):1747–1751 doi:10.1093/carcin/16.8.1747 PubMedCrossRef

18.

Kaminishi M, Shimizu N, Shiomoyama S, Yamaguchi H, Ogawa T, Sakai S, Kuramoto S, Oohara T (1995) Etiology of gastric remnant cancer with special reference to the effects of denervation of the gastric mucosa. Cancer 75(6 Suppl):1490–1496 15;PubMedCrossRef

19.

Nakanishi I, Sowa M, Otani S (1993) Ornithine decarboxylase activity in the mucosa of gastric remnant following gastric surgery. Cancer Epidemiol Biomarkers Prev 2(6):569–572PubMed

20.

Kitao Y, Yamane T, Kikuoka N, Matsumoto H, Oya K, Inagake M et al (1994) Risk analysis of carcinogenesis in the remnant stomach with measurement of ornithine decarboxylase activity. J Surg Oncol 57(1):22–24 doi:10.1002/jso.2930570107 PubMedCrossRef

21.

Ehrnström RA, Bjursten LM, Ljungberg O, Veress B, Haglund ME, Lindström CG, Andersson T (2008) Dietary supplementation with carbonate increases expression of ornithine decarboxylase and proliferation in gastric mucosa in a rat model of gastric cancer. Int J Cancer 122(4):727–733 15;PubMedCrossRef

22.

Furukawa H, Iwanaga T, Hiratsuka M, Imaoka S, Ishikawa O, Kabuto T et al (1993) Gastric remnant cancer as a metachronous multiple lesion. Br J Surg 80(1):54–56 doi:10.1002/bjs.1800800120 PubMedCrossRef

23.

Sasako M, Maruyama K, Kinoshita T, Okabayashi K (1991) Surgical treatment of carcinoma of the gastric stump. Br J Surg 78(7):822–824 doi:10.1002/bjs.1800780718 PubMedCrossRef

24.

Piso P, Meyer HJ, Edris C, Jähne J (1999) Surgical therapy of gastric stump carcinoma—a retrospective analysis of 109 patients. Hepatogastroenterology 46(28):2643–2647PubMed

25.

Ikeguchi M, Kondou A, Shibata S, Yamashiro H, Tsujitani S, Maeta M et al (1994) Clinicopathologic differences between carcinoma in the gastric remnant stump after distal partial gastrectomy for benign gastroduodenal lesions and primary carcinoma in the upper third of the stomach. Cancer 73(1):15–21 doi:10.1002/1097-0142(19940101)73:1<15::AID-CNCR2820730105>3.0.CO;2-J PubMedCrossRef

26.

Lacaine F, Houry S, Huguier M (1992) Stomach cancer after partial gastrectomy for benign ulcer disease. A critical analysis of epidemiological reports. Hepatogastroenterology 39(1):4–8PubMed

Title: Gastric remnant cancer: an old problem with novel concerns
Authors: Ozgur Firat
Adem Guler
Murat Sozbilen
Sinan Ersin
Hasan Kaplan
Publication date: 01-01-2009
Publisher: Springer-Verlag
Published in: Langenbeck's Archives of Surgery / Issue 1/2009
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI: https://doi.org/10.1007/s00423-008-0382-7

At a glance: The STEP trials

Springer Medicine

Gastric remnant cancer: an old problem with novel concerns

Abstract

Background and aims

Patients and methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Background and aims

Patients and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2009

Occult disseminated tumor cells in lymph nodes of patients with gastric carcinoma. A critical appraisal of assessment and relevance

Palliative operation for the treatment of alveolar echinococcosis

Interleukin-2 immunotherapy action on innate immunity cells in peripheral blood and tumoral tissue of pancreatic adenocarcinoma patients

Clinicopathologic characteristics of gastric cancer patients who underwent noncurative gastrectomy with long-term survival

New randomized trial of probiotics in pancreatitis needed? Caution advised

The unbearable lightness of understanding clinical influence of lymph node micrometastasis